Categories
-
Adhesives
5
Amines
92
Amino Acids
179
Analytical Reagents
668
Antibiotics
247
Bioactive Small Molecules
715
Aroma Chemicals
203
Biochemicals
1003
Boronic Acids
4
Buffers
96
Building Blocks
1759
Carbohydrates
176
Catalysts
96
Chiral Compounds
53
Coccus nucifera oil
0
Detergents
57
Diagnostic Raw Materials
257
Flavours and Fragrance Materials
202
Fluorinated Products
43
Furans
5
Gases in Solution
47
Grignard Reagents
18
HPLC Reagents
8
Imidazoles
17
Indoles
41
Inorganic Chemicals
321
Ion-Pair Reagents
24
Ligands
79
Organics
1295
Oxazoles
3
Peptide Reagents
89
Phenols
45
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
42
Reagents
97
Research Organics & Inorganics
753
Salts
281
Sealing Compounds
1
Sherclin
1
Solvents
121
Stains & Indicators
292
Sugars
63
Tailor-made solutions
1
Testing Standards
4
Uncategorised
90
Water Analysis
12
DL-Noradrenaline hydrochloride
(37506482 | 55-27-6)
CAS: | 55-27-6 |
---|---|
Molecular Formula: | C8H11NO3 · HCl |
Molecular Weight: | 205.64 |
Availablility: | In Stock |
---|---|
Downloads: |
This product is subject to a hazardous surcharge. The exact amount will be confirmed by our sales team.
37506482-5g | 5g | £123.90 | |
Bulk Order |
37506482-5g | 5g | €173.50 | |
Bulk Order |
37506482-5g | 5g | $185.90 | |
Bulk Order |
Specification
Certificate of Analysis
Product Detail
Product Code | 37506482 | ||||
Product Name | DL-Noradrenaline hydrochloride | ||||
Categories | Bioactive Small Molecules Biochemicals Research Organics & Inorganics | ||||
CAS | 55-27-6 | ||||
Molecular Formula | C8H11NO3 · HCl | ||||
Molecular Weight | 205.64 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 29379000 |
Product Specification
Melting Point | 146 - 154 Deg C | ||||
Water | <0.5% | ||||
Ash | <0.5% | ||||
Specific rotation | -1 to +1 | ||||
Assay | 97.0 - 102.0% | ||||
Organic impurities | <0.5% | ||||
Appearance | White to off-white powder |
Safety Information
Pictograms |
|
||||
Signal word | danger | ||||
Hazard statements |
|
||||
Precautionary statements |
|